Ulf-Henrik Mellqvist

Ulf-Henrik Mellqvist

UNVERIFIED PROFILE

Are you Ulf-Henrik Mellqvist?   Register this Author

Register author
Ulf-Henrik Mellqvist

Ulf-Henrik Mellqvist

Publications by authors named "Ulf-Henrik Mellqvist"

Are you Ulf-Henrik Mellqvist?   Register this Author

38Publications

325Reads

[Heart transplantation in AL amyloidosis].

Lakartidningen 2018 Mar 26;115. Epub 2018 Mar 26.

Sahlgrenska universitetssjukhuset - Kardiologen Göteborg, Sweden - Cardiology Gothenburg, Sweden.

View Article
March 2018

Global myeloma research clusters, output, and citations: a bibliometric mapping and clustering analysis.

PLoS One 2015 28;10(1):e0116966. Epub 2015 Jan 28.

Department of Haematology, Aalborg University Hospital, Aalborg, Denmark; European Myeloma Network Board, Aalborg, Denmark; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

View Article
October 2015

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Nat Commun 2015 May 26;6:7213. Epub 2015 May 26.

1] Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, BMC B13, SE-221 84 Lund, Sweden [2] Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Office of Medical Services, Akutgatan 8, SE-221 85 Lund, Sweden [3] Broad Institute, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.

View Article
May 2015

New prognostic tools for myeloma.

Blood 2015 Mar;125(13):2014-5

GOTHENBURG UNIVERSITY.

View Article
March 2015

Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.

Haematologica 2015 Jan 24;100(1):107-13. Epub 2014 Oct 24.

Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

View Article
January 2015

Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.

Haematologica 2012 Jun 16;97(6):854-8. Epub 2011 Dec 16.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
June 2012

Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study.

Blood 2011 Dec 13;118(24):6284-91. Epub 2011 Oct 13.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
December 2011

Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation.

Eur J Haematol 2011 Aug;87(2):117-22

Section of Hematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.

View Article
August 2011

Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study.

Blood 2010 Oct 7;116(15):2651-5. Epub 2010 Jul 7.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
October 2010

Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.

Blood 2010 Jun 18;115(24):4991-8. Epub 2010 Mar 18.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
June 2010

Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.

Haematologica 2009 Dec 16;94(12):1714-20. Epub 2009 Jul 16.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
December 2009

Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.

Int J Cancer 2009 Nov;125(9):2147-50

Department of Medicine, Division of Hematology, Karolinska University Hospital, Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
November 2009

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.

Blood 2009 Jul 30;114(4):791-5. Epub 2009 Jan 30.

Division of Cancer Epidemiology and Genetics, and Center for Cancer Research, Medical Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA.

View Article
July 2009

Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma.

Blood 2008 Nov 17;112(9):3582-6. Epub 2008 Jun 17.

Department of Medicine, Division of Hematology, Karolinska University Hospital and Institutet, Stockholm, Sweden.

View Article
November 2008

Localization of human neutrophil interleukin-8 (CXCL-8) to organelle(s) distinct from the classical granules and secretory vesicles.

J Leukoc Biol 2006 Mar 30;79(3):564-73. Epub 2005 Dec 30.

University of Göteborg, Guldhedsgatan 10, S 413 46 Göteborg, Sweden.

View Article
March 2006

Oxygen radical-induced natural killer cell dysfunction: role of myeloperoxidase and regulation by serotonin.

J Leukoc Biol 2004 Jun 23;75(6):1111-5. Epub 2004 Mar 23.

Göteborg University, Guldhedsgatan 10 B, S-413 46 Göteborg, Sweden.

View Article
June 2004

Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils.

BMC Cell Biol 2004 May 24;5:21. Epub 2004 May 24.

Department of Rheumatology and Inflammation Research, University of Göteborg, Sweden.

View Article
May 2004

[CPP (Cost Per Patient) is functioning well in the everyday care. The myeloma care program in Vastra Gotaland--an illustrative example].

Lakartidningen 2003 Oct;100(42):3316-8

Sektionen för hematologi och koagulation, medicinkliniken, Sahlgrenska Universitetssjukhuset, Göteborg.

View Article
October 2003